Holocene Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-158,000
Closed -$51.7M 809
2025
Q4
$51.7M Buy
+158,000
New +$50.1M 0.11% 206
2025
Q1
Sell
-227,000
Closed -$59.2M 735
2024
Q4
$59.2M Buy
+227,000
New +$67.3M 0.19% 146
2018
Q1
Sell
-5,395
Closed -$938K 535
2017
Q4
$938K Buy
+5,395
New +$955K 0.02% 171

Other funds holding AMGN

Holocene Advisors's AMGN Position: Q1 2026 in Review

Holocene Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 158,000 shares — an estimated $51.7M sold.

Holocene Advisors first reported a position in AMGN in Q4 2017 and held it in 3 quarters. The position peaked at $59.2M in Q4 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Holocene Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Holocene Advisors sold 158,000 Amgen shares in Q1 2026, an estimated $51.7M.
  • Holocene Advisors first reported a position in Amgen in Q4 2017 and held it in 3 quarters.
  • Holocene Advisors's Amgen position peaked at $59.2M in Q4 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.